The American Lung Association, currently funding more than $6.49 million in groundbreaking research, continues its investment in lung health research, expecting to offer at least $6.5 million dollars in new grants in fiscal year 2017, including a new research award with a focus on lung cancer in women.

GE Healthcare’s new low-dose screening reference protocols have been cleared by the FDA for lung cancer screening.

SHINE Medical Technologies, a Wisconsin-based medical isotope company, announced today that it has been awarded $150,000 from the National Science Foundation for Phase I of an SBIR (Small Business Innovation Research) Grant. 

Nebraska Native, CEO Dr. Randall Jones, leads the industry with world's first non-invasive wearable PROCURETM (Prostate/Pelvic) MRI Coil.

The American Society of Clinical Oncology (ASCO) today released a proposal to significantly improve the quality and affordability of care for cancer patients.

Researchers at Cedars-Sinai Medical Center in Los Angeles are working on a technique that could diagnose brain tumors and treat the cancer with a combination of an MRI “virtual biopsy” and nano-scale drugs. 

Tumor paint, a substance derived from scorpion venom that can cross the blood-brain barrier, can make brain tumors glow under near-infrared light, making them easier targets for surgeons.

Imaging tests like mammograms or CT scans can detect tumors, but figuring out whether a growth is or isn’t cancer usually requires a biopsy to study cells directly. Now results of a Johns Hopkins study suggest that MRI could one day make biopsies more effective or even replace them altogether by noninvasively detecting telltale sugar molecules shed by the outer membranes of cancerous cells.